Salwender H - Search Results

1

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma.

Merz M, Jauch A, Hielscher T, Bochtler T, Schönland SO, Seckinger A, Hose D, Bertsch U, Neben K, Raab MS, Hillengass J, Salwender H, Blau IW, Lindemann HW, Schmidt-Wolf IGH, Scheid C, Haenel M, Weisel KC, Goldschmidt H. Merz M, et al. Among authors: salwender h. Blood Adv. 2017 Dec 27;2(1):1-9. doi: 10.1182/bloodadvances.2017013334. eCollection 2018 Jan 9. Blood Adv. 2017. PMID: 29344579 Free PMC article. Clinical Trial.

2

Large-bore central venous catheters for the collection of peripheral blood stem cells.

Hahn U, Goldschmidt H, Salwender H, Haas R, Hunstein W. Hahn U, et al. Among authors: salwender h. J Clin Apher. 1995;10(1):12-6. doi: 10.1002/jca.2920100104. J Clin Apher. 1995. PMID: 7601862

3

[Ambulatory therapy of multiple myeloma with vincristine, adriamycin and dexamethasone].

Egerer G, Hegenbart U, Salwender H, Hahn U, Haas R, Goldschmidt H, Hunstein W. Egerer G, et al. Among authors: salwender h. Dtsch Med Wochenschr. 1997 Apr 25;122(17):531-5. doi: 10.1055/s-2008-1047649. Dtsch Med Wochenschr. 1997. PMID: 9190299 German.

4

Comparison of oral itasetron with oral ondansetron: results of a double-blind, active-controlled phase II study in chemotherapy-naive patients receiving moderately emetogenic chemotherapy.

Goldschmidt H, Salwender H, Egerer G, Kempe R, Voigt T. Goldschmidt H, et al. Among authors: salwender h. Anticancer Drugs. 1997 Jun;8(5):436-44. Anticancer Drugs. 1997. PMID: 9215605 Clinical Trial.

5

Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatment.

Goldschmidt H, Salwender HJ, Hahn U, Hegenbart U, Egerer G, Wallmeier M, Jansen B, Haas R. Goldschmidt H, et al. Among authors: salwender hj. Zentralbl Bakteriol. 1998 Jan;287(1-2):125-34. doi: 10.1016/s0934-8840(98)80158-8. Zentralbl Bakteriol. 1998. PMID: 9532271

6

Central venous catheter-related complications.

Salwender HJ, Egerer G, Bach A, Hahn U, Goldschmidt H, Ho AD. Salwender HJ, et al. Antibiot Chemother (1971). 2000;50:133-43. doi: 10.1159/000059322. Antibiot Chemother (1971). 2000. PMID: 10874461 Review. No abstract available.

7

Treatment of chemotherapy-induced emesis.

Egerer G, Hegenbart U, Salwender HJ, Goldschmidt H, Ho AD. Egerer G, et al. Among authors: salwender hj. Antibiot Chemother (1971). 2000;50:171-83. doi: 10.1159/000059326. Antibiot Chemother (1971). 2000. PMID: 10874465 Review. No abstract available.

8

Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone.

Egerer G, Hegenbart U, Salwender H, Haas R, Hahn U, Schmier JW, Ho AD, Goldschmidt H. Egerer G, et al. Among authors: salwender h. Support Care Cancer. 2001 Jul;9(5):380-5. doi: 10.1007/s005200000224. Support Care Cancer. 2001. PMID: 11497393

9

Harter C, Salwender HJ, Bach A, Egerer G, Goldschmidt H, Ho AD. Harter C, et al. Among authors: salwender hj. Cancer. 2002 Jan 1;94(1):245-51. doi: 10.1002/cncr.10199. Cancer. 2002. PMID: 11815983 Free article. Clinical Trial.

10

Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.

Ostendorf T, Meinhold A, Harter C, Salwender H, Egerer G, Geiss HK, Ho AD, Goldschmidt H. Ostendorf T, et al. Among authors: salwender h. Support Care Cancer. 2005 Dec;13(12):993-1000. doi: 10.1007/s00520-005-0812-9. Epub 2005 Apr 16. Support Care Cancer. 2005. PMID: 15834740 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters